InvestorsHub Logo
Post# of 251923
Next 10
Followers 829
Posts 119685
Boards Moderated 16
Alias Born 09/05/2002

Re: DewDiligence post# 242322

Tuesday, 01/03/2023 6:46:18 PM

Tuesday, January 03, 2023 6:46:18 PM

Post# of 251923
PHAT—(-25%/AH)—discloses that its NDA for vonoprazan monotherapy in erosive esophagitis is
in limbo due to nitrosamine contamination:

https://finance.yahoo.com/news/phathom-pharmaceuticals-provides-drug-application-210100715.html

The PDUFA date had been 1/11/23.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.